Q4 2025 earnings call recap: customer growth, ARPAC gains, profits, credit trends, and 2026 AI + global expansion plans—read now.

Nu Holdings Ltd (NU) reports robust financial performance with significant customer growth and strategic investments for future expansion.

Q4 2025 earnings call highlights: record $62.1M revenue, Aurora Evo growth, recurring revenue gains, and 2026 guidance.

Despite achieving record revenue, Cytek Biosciences Inc (CTKB) faces profitability pressures due to increased costs and a net loss in Q4 2025.

Launch of Horizons strategic planParis, February 24th, 2026 -Ipsos, one of the world's leading market research ...

Launch of Horizons strategic plan Paris, February 24th, 2026 - Ipsos, one of the world's leading market research and opinion polling companies, today announces ...

Globant (NYSE: GLOB) today announced results for the three and twelve months ended December 31, 2025. "Twenty-three years ago, we set out to build a company that would reinvent how technology gets ...

Rare disease drug developers struggle to survive in a biopharma investment market that prioritizes large patient populations.

FULL-YEAR RESULTS PAREF strengthens its fundamentals and initiates strategic refocusing REIT activity: a portfolio in transition in a challenging market €174m of owned asset, decreasing by ...

For decades, retirement planning has focused on saving aggressively, investing consistently and preparing for rising healthcare costs. HSAs help change the conversation.